Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells

被引:87
作者
Knight, MJ
Riffkin, CD
Muscat, AM
Ashley, DM
Hawkins, CJ
机构
[1] Royal Childrens Hosp, Dept Haematol & Oncol, Parkville, Vic 3052, Australia
[2] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia
[3] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia
[4] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia
基金
英国医学研究理事会;
关键词
apoptosis; glioma; resistance; TRAIL; Fas; Bcl-2;
D O I
10.1038/sj.onc.1204810
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FasL and TNF-related apoptosis-inducing ligand (TRAIL) belong to a subgroup of the TNF superfamily which induce apoptosis by binding to their death domain containing receptors. In the present study we have utilized a panel of seven cell lines derived from human malignant gliomas to characterize molecular pathways through which FasL and TRAIL induce apoptosis in sensitive glioma cells and the mechanisms of resistance in cell lines which survive the death stimuli. Our findings indicate that FADD and Caspase-8 are essential for FasL and TRAIL mediated apoptosis in glioma cells. One sensitive cell line (D270) can be protected from FasL and TRAIL induced death by anti-apoptotic Bcl-2 family members while another (D645) cannot, implying that these lines may represent glioma examples of type II and type I cells respectively. For the first time we demonstrate resistance to FasL but not to TRAIL within the one glioma cell line. Furthermore, we report distinct mechanisms of resistance within different glioma lines, including downregulation of Caspase-8 in U373MG. Cycloheximide sensitized four of the resistant cell lines suggesting the presence of labile inhibitors. None of the known apoptosis inhibitors examined accounted for the observed resistance, suggesting novel inhibitors may exist in glioma cells.
引用
收藏
页码:5789 / 5798
页数:10
相关论文
共 65 条
[51]   Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis [J].
Strasser, A ;
Harris, AW ;
Huang, DCS ;
Krammer, PH ;
Cory, S .
EMBO JOURNAL, 1995, 14 (24) :6136-6147
[52]   Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN [J].
Teitz, T ;
Wei, T ;
Valentine, MB ;
Vanin, EF ;
Grenet, J ;
Valentine, VA ;
Behm, FG ;
Look, AT ;
Lahti, JM ;
Kidd, VJ .
NATURE MEDICINE, 2000, 6 (05) :529-535
[53]   Temperature-sensitive differential affinity of TRAIL for its receptors - DR5 is the highest affinity receptor [J].
Truneh, A ;
Sharma, S ;
Silverman, C ;
Khandekar, S ;
Reddy, MP ;
Deen, KC ;
Mclaughlin, MM ;
Srinivasula, SM ;
Livi, GP ;
Marshall, LA ;
Alnemri, ES ;
Williams, WV ;
Doyle, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :23319-23325
[54]   Inhibition of Fas death signals by FLIPs [J].
Tschopp, J ;
Irmler, M ;
Thome, M .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :552-558
[55]   Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells [J].
Wen, JH ;
Ramadevi, N ;
Nguyen, D ;
Perkins, C ;
Worthington, E ;
Bhalla, K .
BLOOD, 2000, 96 (12) :3900-3906
[56]   Suicidal tendencies: Apoptotic cell death by caspase family proteinases [J].
Wolf, BB ;
Green, DR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20049-20052
[57]   Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis [J].
Wrone-Smith, T ;
Izban, KF ;
Ergin, M ;
Cosar, EF ;
Hsi, ED ;
Alkan, S .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (05) :572-581
[58]  
Wu M, 2000, J NEUROSCI RES, V61, P464, DOI 10.1002/1097-4547(20000815)61:4<464::AID-JNR14>3.0.CO
[59]  
2-G
[60]   The molecular interaction of Fas and FAP-1 - A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis [J].
Yanagisawa, J ;
Takahashi, M ;
Kanki, H ;
YanoYanagisawa, H ;
Tazunoki, T ;
Sawa, E ;
Nishitoba, T ;
Kamishohara, M ;
Kobayashi, E ;
Kataoka, S ;
Sato, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8539-8545